Trial: 201711133

Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) in muScle invaSive and locally ADvanced urOthelial caRcinoma” (AMBASSADOR) versus observation

Phase

III

Principal Investigator

Picus, Joel

Disease Site

Urinary Bladder

Learn more about this study at: clinicaltrials.gov